Related Experiment Video
Updated: Apr 18, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Primary care management of early stage chronic lymphocytic leukaemia is safe and effective
H M Parry1, S Damery2, N P Mudondo3
1From the Cancer Sciences.
Insights
Management of early-stage Chronic Lymphocytic Leukaemia (CLL) in primary care or secondary care showed equivalent outcomes. This study suggests primary care management for stable-stage A0 CLL is a viable option.
Area of Science:
- Oncology
- Haematology
- Public Health
Background:
- Chronic Lymphocytic Leukaemia (CLL) is the most common leukaemia in Western societies.
- Early-stage CLL patients often require 'watch and wait' management.
- Current UK management strategies for Stage A0 CLL vary between primary and secondary care, with unknown safety and effectiveness.
Purpose of the Study:
- To compare the safety and effectiveness of primary care versus haematology outpatient management for stable-stage A0 CLL.
- To evaluate clinical outcomes including disease progression, treatment initiation, and mortality.
Main Methods:
- An observational retrospective cohort study was conducted.
- Patients diagnosed with stable Stage A0 CLL between 2002 and the study period were identified.
- Comparison of outcomes between patients managed in primary care versus haematology clinics.
Main Results:
- 246 Stage A0 CLL patients were analyzed; 43% were managed in primary care and 57% in haematology clinics.
- No significant differences in mortality or the need for treatment were observed between the two management groups.
- The majority (66%) of patients discharged to primary care remained under its care.
Conclusions:
- Management of stable-stage A0 CLL in either primary or secondary care yields equivalent clinical outcomes.
- Primary care management for stable-stage A0 CLL is a potentially effective approach, especially considering the increasing prevalence of early-stage CLL.
- This study supports the consideration of primary care-based management for stable early-stage CLL.
Background:
Chronic lymphocytic leukaemia (CLL) is the commonest leukaemia in western society. Most patients are detected incidentally at an early stage and require 'watch and wait' follow-up. In the UK, management of Stage A0 CLL varies with some centres advising regular outpatient haematology follow-up, whereas others recommend management within primary care. The safety and effectiveness of these two management options are currently unknown.
Methods:
An observational retrospective cohort study in outpatient Haematology clinics at Queen Elizabeth Hospital Birmingham (QEH) and Birmingham Heartlands Hospital (BHH) and primary care practices in West Midlands, UK. All patients diagnosed with stable stage A0 CLL since 2002 at BHH or QEH were identified. At BHH, patients were discharged to primary care follow-up, whilst QEH patients remained under haematology for follow-up. Evidence of disease progression, need for treatment and overall mortality was documented.
Results:
Two hundred and forty-six Stage A0 CLL patients were identified. One hundred and five (43%) patients were discharged to primary care, whilst 141 (57%) patients were followed up in haematology outpatient clinics. No difference in mortality or need for treatment was found between the two groups. Of those discharged, 93 (66%) remained in primary care.
Conclusion:
The management of stable-stage A0 CLL within primary or secondary care leads to equivalent clinical outcomes. The prevalence of early-stage CLL is expected to increase with the ageing population and management within primary care should be considered as a potentially effective approach.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Kidney Disease IV: Nursing Management
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Myocarditis IV: Nursing Management

